Christopher Scott Bryan - Net Worth and Insider Trading
Christopher Scott Bryan Net Worth
The estimated net worth of Christopher Scott Bryan is at least $6,843 dollars as of 2024-09-21. Christopher Scott Bryan is the Senior Officer of Algernon Pharmaceuticals Inc and owns about 80,500 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) stock worth over $6,843. Details can be seen in Christopher Scott Bryan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Scott Bryan has not made any transactions after 2024-05-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Scott Bryan
Christopher Scott Bryan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Scott Bryan owns 1 companies in total, including Algernon Pharmaceuticals Inc (XCNQ:AGN) .
Click here to see the complete history of Christopher Scott Bryan’s form 4 insider trades.
Insider Ownership Summary of Christopher Scott Bryan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XCNQ:AGN | Algernon Pharmaceuticals Inc | 2024-05-17 | Senior Officer |
Christopher Scott Bryan Latest Holdings Summary
Christopher Scott Bryan currently owns a total of 1 stock. Christopher Scott Bryan owns 80,500 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) as of May 17, 2024, with a value of $6,843.
Latest Holdings of Christopher Scott Bryan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XCNQ:AGN | Algernon Pharmaceuticals Inc | 2024-05-17 | 80,500 | 0.09 | 6,843 |
Holding Weightings of Christopher Scott Bryan
Christopher Scott Bryan Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Scott Bryan has made a total of 3 transactions in Algernon Pharmaceuticals Inc (XCNQ:AGN) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Algernon Pharmaceuticals Inc is the acquisition of 20,500 shares on May 17, 2024, which cost Christopher Scott Bryan around $2,870.
Insider Trading History of Christopher Scott Bryan
- 1
Christopher Scott Bryan Trading Performance
GuruFocus tracks the stock performance after each of Christopher Scott Bryan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Scott Bryan is -2.11%. GuruFocus also compares Christopher Scott Bryan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Scott Bryan within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher Scott Bryan's insider trading performs compared to the benchmark.
Performance of Christopher Scott Bryan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.26 |  | | | | |
| Relative Return to S&P 500(%) | 16.46 | | | | | |
Christopher Scott Bryan Ownership Network
Christopher Scott Bryan Owned Company Details
What does Algernon Pharmaceuticals Inc do?
Who are the key executives at Algernon Pharmaceuticals Inc?
Christopher Scott Bryan is the Senior Officer of Algernon Pharmaceuticals Inc. Other key executives at Algernon Pharmaceuticals Inc include Director & Senior Officer Christopher Moreau , Senior Officer James Kinley , and Senior Officer Michael Sadhra .
Algernon Pharmaceuticals Inc (XCNQ:AGN) Insider Trades Summary
Over the past 18 months, Christopher Scott Bryan made 3 insider transaction in Algernon Pharmaceuticals Inc (XCNQ:AGN) with a net purchase of 60,500. Other recent insider transactions involving Algernon Pharmaceuticals Inc (XCNQ:AGN) include a net purchase of 52,500 shares made by Christopher Moreau , a net purchase of 12,500 shares made by James Kinley ,
In summary, during the past 3 months, insiders sold 0 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) were sold and 125,500 shares were bought by its insiders, resulting in a net purchase of 125,500 shares.
Algernon Pharmaceuticals Inc (XCNQ:AGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Algernon Pharmaceuticals Inc Insider Transactions
Christopher Scott Bryan Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Scott Bryan. Currently GuruFocus does not have mailing address information for Christopher Scott Bryan.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
